<DOC>
	<DOCNO>NCT00178971</DOCNO>
	<brief_summary>Examines cognitive functioning patient schizophrenia schizoaffective disorder treat antipsychotic medication . Patients assign take active medication ( Buspar ) placebo along prescribed antispycotic medication six week . Patients ' memory problem-solving ability test medication .</brief_summary>
	<brief_title>Serotonin 1A Agonists Cognition Schizophrenia</brief_title>
	<detailed_description>Examines cognitive functioning patient schizophrenia schizoaffective disorder treat olanzapine risperidone least three month randomize receive adjunctive treatment 5-HT1A agonist ( buspirone , 15-30 mg/day ) placebo .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Subjects must meet follow criterion eligible participation current research study . 1 . Subjects males female 1865 year age ; 2 . Subjects definite diagnosis DSMIV criterion Schizophrenia Schizoaffective Disorder ; 3 . The subject legal guardian must sign informed consent ; 4 . Subjects currently treat olanzapine risperidone duration least 3 month 1 . Subjects pregnant lactate 2 . Subjects brain damage and/or neurological disorder 3 . Subjects current substance dependence 4 . Subjects unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>